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Abstract
Background: Screening and counseling for genetic conditions is an increasingly important part of primary care
practice, particularly given the paucity of genetic counselors in the United States. However, primary care physicians
(PCPs) often have an inadequate understanding of evidence-based screening; communication approaches that
encourage shared decision-making; ethical, legal, and social implication (ELSI) issues related to screening for genetic
mutations; and the basics of clinical genetics. This study explored whether an interactive, web-based genetics
curriculum directed at PCPs in non-academic primary care settings was superior at changing practice knowledge,
attitudes, and behaviors when compared to a traditional educational approach, particularly when discussing
common genetic conditions.
Methods: One hundred twenty one PCPs in California and Pennsylvania physician practices were randomized to
either an Intervention Group (IG) or Control Group (CG). IG physicians completed a 6 h interactive web-based
curriculum covering communication skills, basics of genetic testing, risk assessment, ELSI issues and practice
behaviors. CG physicians were provided with a traditional approach to Continuing Medical Education (CME) (clinical
review articles) offering equivalent information.
Results: PCPs in the Intervention Group showed greater increases in knowledge compared to the Control Group.
Intervention PCPs were also more satisfied with the educational materials, and more confident in their genetics
knowledge and skills compared to those receiving traditional CME materials. Intervention PCPs felt that the web-based
curriculum covered medical management, genetics, and ELSI issues significantly better than did the Control Group, and
in comparison with traditional curricula. The Intervention Group felt the online tools offered several advantages, and
engaged in better shared decision making with standardized patients, however, there was no difference in behavior
change between groups with regard to increases in ELSI discussions between PCPs and patients.
Conclusion: While our intervention was deemed more enjoyable, demonstrated significant factual learning and
retention, and increased shared decision making practices, there were few differences in behavior changes around ELSI
discussions. Unfortunately, barriers to implementing behavior change in clinical genetics is not unique to our
intervention. Perhaps the missing element is that busy physicians need systems-level support to engage in meaningful
discussions around genetics issues. The next step in promoting active engagement between doctors and patients may
be to put into place the tools needed for PCPs to easily access the materials they need at the point-of-care to engage
in joint discussions around clinical genetics.
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Background
Screening and counseling for genetic conditions is an in-
creasingly important part of primary care practice, particu-
larly given the paucity of genetic counselors in the United
States [1] Discussions about genetic risk-assessment in-
crease patients’ knowledge of genetics, improve the accur-
acy of their perceived personal risk, and reduce their
psychological distress [2]. However, primary care physicians
often have an inadequate understanding with regard to
evidence-based screening for genetic issues, and a lack of
confidence in communicating about shared decision-
making, and about legal, ethical, and social issues related to
screening for genetic mutations and the basics of clinical
genetics [3–7]. Increasing clinician knowledge and confi-
dence in these areas can be challenging. While genetics is a
rapidly expanding field, the majority of PCPs are not
instructed on these issues during their medical training,
and there are few non-industry sponsored education oppor-
tunities available to learn the material after the fact. When
there is poor physician communication and knowledge, or
when the primary care physician (PCP) is unprepared to
engage in shared decision-making, the result can be poor
medical care – either unnecessary and expensive over test-
ing or inappropriate and potentially dangerous under test-
ing. The result is both an underutilization of genetic
counseling, failure to test patients most at risk [4, 8] and an
overutilization of testing for those at low risk [9]. When
counseling is offered, PCPs often find the task of communi-
cating genetic risks to their patients challenging and give
disproportionate attention to screening advantages over
disadvantages [10]. Meanwhile, many patients in the U.S.
believe that general practitioners are not competent to han-
dle queries about genetic conditions adequately [11]. Thus,
there is a clear need for interventions that teach risk assess-
ment [12] and improve provider confidence and adherence
to evidence-based genetic counseling and testing recom-
mendations [9, 13].
Evaluations of genetic education material, videos, decision
aids, and software programs geared towards the patient
have been reported elsewhere [14–19], and several inter-
ventions aimed at using interactive curriculum to increase
clinician knowledge and attitudes around genetics have
been shown to be successful [20, 21]. However few studies
have sought to improve physician knowledge, attitudes,
communication skills, and measured clinician behavior
change following the intervention [21]. Thus, the present
study explored whether the development and evaluation of
an interactive, web-based genetics curriculum directed at
PCPs in non-academic primary care settings was superior
at changing not only knowledge, confidence, and attitudes
with regard to genetic communication, but also was super-
ior in eliciting desired practice behaviors compared with
traditional educational approaches. Elsewhere, we have re-
ported on the metrics and outcomes of the practice
behavior [22]. In this paper, we focus on the curriculum’s
collective impact on clinician knowledge, attitudes, shared
decision making practices, and behaviors around genetic is-
sues, and discuss the implications for genetics focused edu-
cational interventions moving forward.
Methods
In this study, 121 California and Pennsylvania PCPs were
randomized to either an Intervention Group or Control
Group. Physicians in the Intervention Group completed a
6 h interactive web-based curriculum covering informa-
tion about genetic testing, risk assessment, practice behav-
iors, attitudes, and communication skills. Physicians in the
Control Group were provided with a traditional approach
to Continuing Medical Education (CME) (clinical review
articles) offering equivalent information. Here we report
the effects of the intervention on physicians’ knowledge,
attitudes, and intended behaviors.
Setting and participants
The study took place in two regions of California (Northern
California in the greater Sacramento area and in Southern
California in the Los Angeles region) and in central Penn-
sylvania. PCPs were eligible to participate if they were a
Medical Doctor (MD) or Doctor of Osteopathy (DO), a
family physician or a general internist, English speaking, did
not practice full time in a university setting, and had inter-
net and e-mail access. In California, a list of PCPs was com-
piled through an internet search of the California Medical
Board. Physicians were then sent information about the
study through faxes and flyers. Colleagues at clinics in two
large health systems made recruitment appeals on our
behalf. In Pennsylvania, PCPs were identified via the Penn-
sylvania Area Health Education Center, which sent person-
alized letters of invitation, recruitment flyers, and business
reply postcards to prospective participants. Using a pur-
chased mailing list, the Pennsylvania State University (PSU)
team sent recruitment materials to PCP’s around the state.
Participation follows the flow diagram (Fig. 1). Participants
were offered 6 units of CME credit and a payment of $250
upon completion of study activities; credit and payment
were not affected by individual performance during the
standardized patient assessment exercise.
Design and procedure overview
Study procedures were approved by Institutional Review
Boards (IRB) at the University of California, Davis and
Pennsylvania State University. Intervention Group (n = 60)
and Control Group (n = 61) PCPs were instructed how to
access the curricula learning materials and asked to
complete all materials within 60 days. Curricula could be
accessed from any web-enabled computer with a moderate
speed internet connection.
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Upon enrollment, physicians participated in a pre-
intervention objective structured video exercise (OSVE)
described further below, filled out an online pre-visit
questionnaire, completed the educational curriculum,
took an online post-visit survey, and finally completed a
post-intervention OSVE. After finishing the curriculum,
a standardized patient (SP) visit was scheduled. PCPs
were only told the SP would be used to evaluate the cur-
riculum; no mention was made of the clinical condition
(breast cancer) that would be presented to them. SP
visits took place an average of 5 weeks after completion
of the curriculum, and were audio-taped, transcribed,
coded, and evaluated.
Intervention and control group curricula
Intervention group
Using Kern’s curricular development model [23], a group
of 20 consultants with expertise in medical genetics, eth-
ics, law, medical anthropology, clinical medicine, educa-
tional assessment, and educational technology from six
institutions developed curricular content [24]. Essential
ELSI (ethical, legal, and social issues) genetics competen-
cies were identified from organizational recommenda-
tions [25] and published reports [26]. Cases illustrated
common genetic conditions likely to be encountered by
PCPs, and each was linked to competencies/learning-ob-
jectives. Intervention Group physicians completed a 6 h
interactive web-based curriculum (eDoctoring found at
http://edoc.ucdavis.edu/Public_site/) covering informa-
tion about genetic testing, risk assessment, practice be-
haviors, and communication skills. The curriculum
featured four clinical patient cases (breast cancer, cystic
fibrosis, Huntington’s disease, and venous thrombo-
embolism). Each case took 20–30 min to complete and
contained multiple video-vignettes (e.g. interactions be-
tween patients and physicians) to highlight tensions and
communication approaches. Each video or interactive
exercise was followed by a relevant discussion between
animated physician cartoon characters (aka avatars).
Within each case, learners answered closed and open-
Fig. 1 Study Flow Diagram
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ended questions to promote understanding and engage-
ment. Some cases also contained unscripted interviews
with real patients or experts to illustrate certain points.
Genetics content that applied to more than one case
was developed into four content packages called “tuto-
rials” that ran outside of the cases but within the eDoc-
toring tool. The required tutorials were chosen based on
desired learning outcomes and consisted of: 1) core con-
cepts in genetics, 2) core concepts related to screening
and testing for disease, 3) ethics and legal issues related
to clinical genetics, and 4) shared decision making. Each
tutorial took approximately 20–120 min to complete
and contained patient focused videos and interactive
text. Each case and tutorial included video-vignettes that
modeled physician communication, raised questions re-
quiring application of principles, and provided hyper-
links to additional written and video materials. For
intervention group clinicians, completion of all four
cases and four tutorials was required before they could
move on in the study.
eDoctoring was programmed at the University of
Newcastle, UK using Flash and Python, linked to
MySQL (an open-source relational database manage-
ment system (RDBMS)) using Zope (a free and open-
source web application server written in the Python
programming language) and housed on multiple servers
in the UK and US allowing hundreds of learners to be
on-line simultaneously. The curriculum was alpha-
tested with final year primary care residents to improve
flow, consistency and navigation.
Control group
Control Group participants read eight review articles
from leading journals and information sheets ex-
tracted from the National Cancer Institute website
[27–35]. These nine resources covered clinical genet-
ics, ethical issues, doctor-patient issues, and clinical
reasoning, and were topically similar to the material
contained in the Intervention Group. Care was taken
to ensure that learning objectives and messaging be-
tween intervention and Control Group readings were
consistent. Participant access and downloading of the
articles was recorded electronically. It was estimated
that physicians would need at least 6 h to read all ar-
ticles. While we cannot say how completely or thor-
oughly the articles were read by control group
clinicians, our tracking system allowed us to see that
86% of participants opened the PDFs. The educational
Control Group allowed us to examine the impact of
our web-based curriculum relative to a more trad-
itional learning format rather than comparing our
tools to untaught physicians, which would have been
an easy but meaningless comparison.
Survey instrument development
Before accessing their respective learning tools, learners in
both the intervention and Control Group participated in an
online, pre-curricular survey to collect information about
demographics (3 items), self-efficacy (28 items), knowledge
(43 items), and prior experience (13 items) with ELSI and
core genetics. The self-efficacy, knowledge, and attitude/ex-
perience items were developed based on the learning objec-
tives and published standards from professional groups.
[24, 36] Items were later used to form scales to assess im-
provement from pre to post testing.
Self-efficacy
Self-efficacy items [37] were introduced with the stem,
“How confident are you about your current skills…”
Learners rated their confidence from “not at all confident”
[1] to “extremely confident” [5] in a variety of areas.
Twenty general self-efficacy items were classified into 2
domains — self-efficacy for genetically related clinical
skills (e.g., communication, patient teaching, shared
decision-making) and self-efficacy related to genetics
knowledge. Psychometric item analysis and maximum like-
lihood factor analysis (with varimax rotation) were then
used to assess scale internal consistency and dimensional-
ity. Scale refinement was conducted by using baseline data
to develop initial scales and follow-up data for validation.
In looking at the overall correlations among items in both
domains, we found that by dropping one item from the
clinical self-efficacy set, we could improve the overall
alpha value. After dropping this item, the Cronbach alpha
value for clinical skills self-efficacy was .87, and .76 for
genetic knowledge self-efficacy.
Knowledge
Knowledge was evaluated using an instrument developed
for this study, consisting of 38 true/false and multiple
choice items. The questions addressed 6 areas of genetics
relevant to primary care providers: 1) breast/ovarian can-
cer genetics, 2) genetic testing, 3) shared decision making,
4) ethical/legal/social issues, 5) venous thromboembolism,
and 6) perinatal/pediatric genetic testing. Eleven items re-
lated to knowledge about BRCA genetics and breast/ovar-
ian cancer risk, five items related to steps to be taken
prior to ordering a genetic test, six items related to shared
decision making, six items related to knowledge about
ethics, the law, and confidentiality with regard to genetic
testing, five items related to general genetics and venous
thromboembolism and five items related to ethics and
perinatal/pediatric genetic testing.
In both the Intervention and Control Groups, a know-
ledge test was administered pre- and post-education,
and a change score was calculated based on the percent
of correct responses. An overall score was also calcu-
lated as a percent of correct responses to all items, and
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compared pre-post and between groups. The Cronbach
alpha value for the overall knowledge scale ranged from
to .52 pre intervention to .63 post.
Prior experience
We also created scales for questions pertaining to prior
genetic experience (3 items) and attitude questions (12
items). To assess prior experience, learners were asked
about their experience with a number of genetic disorders,
their experience with caring for those whose main issue
was related to a genetic disorder, their experience interact-
ing with genetic counselors or professionals over the past
year, and their experience and behaviors with regard to
genetic test ordering over the past year. To assess atti-
tudes, learners were asked to give true or false responses
to a series of 14 statements regarding ethical, legal, and
social implications of genetic testing. Examination of the
relationships between questions placed within these do-
mains highlighted items that were not correlative, and
these items were thrown out. Through this process, we
obtained measures for the following three domains: ex-
perience with genetic counselors, attitudes toward genetic
screening, and attitudes toward third party access to gen-
etic profiles. The Cronbach alpha values for these mea-
sures were .85, .73, and .91 respectively.
Assessment of learning tool
At the completion of the entire web-based curriculum,
learners in the Intervention Group were asked their over-
all assessment of the curriculum including whether they
would recommend it to others (1 item), overall perceived
quality (1 item) and satisfaction with the curriculum (1
item), comparison to traditional curricula (10 items), and
perceived impact of curriculum (3 items). Participants
were also asked, “In comparison with traditional curricula,
how well does this type of interactive web-based tool meet
the following goals…” followed by 10 items on a 3 point
scales (1 = worse, 2 = the same; 3 = better). Finally,
learners were asked how likely they were to make changes
to patient care as a result of the curriculum (2 items), as
well as perceived barriers in making changes to patient
care (7 items).
Objective structured video exercise (OSVE)
Because the use of standardized patients (SPs) would
have been prohibitively expensive and burdensome, we
instead used standardized videos to evaluate physician
behavior. We designed six objective structured video ex-
ercises (OSVEs) to allow for demonstration of the
learner’s clinical thinking, judgment, and intended be-
haviors in response to illustrative video vignettes that
heavily emphasized management and ethical issues in
genetics care. The goal of the OSVEs was not instruc-
tional; they were used purely as assessment instruments.
Upon initial enrollment, physicians were randomly
assigned to either OSVE track 1 or OSVE track 2. The dif-
ferent tracks corresponded to the order in which they were
shown six 2 to 4 min OSVEs. In the pre-OSVE assessment,
physicians were shown three OSVEs. Set one consisted of
OSVE A, B, and C, while set two consisted of OSVE D, E,
and F. Each of the six OSVEs depicted a doctor-patient/
family interaction surrounding a genetic topic. Physicians
were shown the opposite set containing 3 OSVEs as a post-
intervention. Pre and post OSVEs were matched for con-
tent and clinical management skills required, but the
OSVEs were not identical. Thus, physicians either saw A,
B, and C pre-intervention and D, E, and F post, or vice
versa. In the post test, learners saw the series of videos they
had not seen in the pre-test. After each OSVE video (pre
and post) participants were asked three questions.
Two hundred and forty audio recordings (120 subjects,
pre and post) were transcribed by a professional tran-
scription service. Written transcripts were scored by
trained graduate students according to a matrix designed
and tested by the principal investigators. This matrix
awarded 0, 1, and 2 points each for “key items” present
in the transcript. Items in the matrix highlighted areas
where the learner may have gained understanding or
knowledge from the curriculum. Possible points ranged
from 0 to 12, 0 to 13, and 0 to 16 for OSVE 1 (videos A
and D), 2 (videos B and E), and 3 (videos C and F) re-
spectively. After transcription, 46 randomly selected
transcripts out of the 240 total were scored by a second
trained graduate student to determine coding reliability
and scoring consistency. Both raters were blinded as to
which OSVE was the pre and which was the post. Test-
ing for intra-class correlation statistics showed good reli-
ability between the two coders, with scores no less than
0.69 for the pre-intervention OSVE and 0.70 post-
intervention.
Standardized patients
Due to resource limitations, just one of the four medical
conditions, breast cancer, was portrayed by an SP. Each
physician was visited by one of five trained SPs playing
the identical role of “Catherine Douglas,” a woman at
risk for inherited breast cancer. Standardized patients
were intensively trained on this character and in prepar-
ation for the visit via videos and in-person training ses-
sions. SPs were given extensive background on their
character, family history, and previous medical history.
No medical knowledge of genetics beyond what an in-
formed patient would need to know about breast cancer
was provided. Standardized patients were also trained to
ask specific questions about the condition and its impli-
cations during the encounter. Because of the relative rar-
ity of the medical condition, SP visits were announced
[38–41] i.e. physicians knew the woman was a SP but
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the PCPs did not know until the time of the encounter
the reason for Catherine’s visit to the doctor. All en-
counters were audio recorded and transcribed verbatim.
Details of the standardized patient transcript analysis
have been reported elsewhere. [22] After the interview,
SPs evaluated the physicians on 10 items related to com-
munication style and shared decision making, using a
five point Likert scale.
Analysis
All analyses were performed using SAS Software version
9.3 (SAS Institute, Cary, NC). Before conducting inferential
analyses, all variables were summarized with descriptive
statistics using percentages for categorical variables and
means, medians, and standard deviations for continuous
variables to check for errors or outliers. Histograms were
also plotted to check the overall distribution of continuous
variables. For categorical variables measured only pre-
intervention or post-intervention, comparisons were made
by Intervention Groups using a Chi-square test, and an
exact version of this test was substituted when small cell
counts violated the usual assumptions of the asymptotic
test. A Wilcoxon Rank Sum test was used to test for differ-
ences between Intervention Groups in continuous or or-
dinal variables measured only pre-intervention or post-
intervention given that the distributions of the variables
were not normal enough to warrant a Two-sample t-test.
The distributions of continuous outcome variables were
assessed for normality using histograms, box plots, and
normality plots. For ordinal Likert scale outcome variables,
nonparametric methods such as the Wilcoxon Rank Sum
or Signed Rank tests, which do not require a normal distri-
bution, were used instead.
Changes from pre-intervention to post-intervention in
knowledge, self-efficacy, and OSVE scores were com-
pared within and between Intervention Groups using
two methods of analysis depending on the distribution
of the outcome variable. For outcome variables having
an approximately normal distribution, a linear mixed ef-
fects model was applied that accounts for the correlation
between repeated measures made on the same study
participant. This model included factors for the Inter-
vention Group, the study visit, and the interaction be-
tween those two factors and allowed all of the pertinent
within and between group comparisons to be made. It
also made possible the inclusion of all of the outcome
data measured at each visit regardless of whether a study
participant had complete data at both time points. For
outcome variables that had skewed distributions, a
Table 1 Physician Characteristics by Study Group
Characteristic Control
(n = 61)
Intervention
(n = 60)
Combined
(n = 121)
Pa
Age, mean (SD) 48.7 (9.8) 49.1 (10.6) 48.9 (10.1) 0.81
Years since graduation
from medical school
mean (SD)
21.7 (9.7) 21.3 (12.3) 21.5 (11.0) 0.86
Female, % 34.4 46.7 40.5 0.20
White race, % 67.2 70.0 68.6 0.85
Hispanic, % 4.9 8.3 6.6 0.49
Those with clinical
experience managing
inherited breast cancer, %
49.2 53.3 51.2 0.72
aThe significance of mean differences between study groups were examined with
t-tests. Differences for the categorical demographic and experience variables
were examined with Fisher’s exact test. Nonsignificant differences are suggestive
of successful randomization of participants to the two study arms
Table 2 Group comparisons for knowledge measures at PRE and POST
Variable Pre Post Change (Post-Pre)
N Mean (95% CI) N Mean (95% CI) Mean (95% CI) Within
P-value
Between
P-value
Attitude toward genetic screening (higher=more agreeable, 1-5)*
Control 67 3.3 (3.1, 3.4) 61 3.4 (3.2, 3.5) 0.1 (0.0, 0.3) 0.17 <0.01
Research 68 3.1 (2.9, 3.3) 61 2.9 (2.7, 3.0) -0.2 (-0.4, -0.1) <0.01
Clinical skills self-efficacy (higher=more confident, 1-5)*
Control 67 3.0 (2.9, 3.2) 61 3.6 (3.5, 3.7) 0.6 (0.4, 0.7) <0.01 0.02
Research 68 3.0 (2.8, 3.1) 61 3.8 (3.6, 3.9) 0.8 (0.6, 0.9) <0.01
Genetic knowledge (higher=more knowledge, 1-5)*
Control 67 2.5 (2.4, 2.6) 61 3.3 (3.1, 3.4) 0.8 (0.6, 0.9) <0.01 0.02
Research 68 2.4 (2.3, 2.6) 61 3.4 (3.3, 3.6) 1.0 (0.9, 1.1) <0.01
Attitudes toward third party access to genetic profiles (higher=more agreeable, 1-5)+
Control 67 1.5 (1.3, 1.6) 61 1.5 (1.3, 1.7) 0.1 (-0.2, 0.3) 0.48 0.64
Research 68 1.4 (1.2, 1.5) 61 1.4 (1.2, 1.5) 0.0 (-0.1, 0.1) 1.0
* Linear mixed effects model
+ Signed Rank tests for within group comparisons, Wilcoxon Rank Sum test for between group comparison
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Wilcoxon Signed Rank test was used to test for a signifi-
cant difference from pre to post within each Interven-
tion Group while a Wilcoxon Rank Sum test was used
to test for a significant difference between the Interven-
tion Groups in the change from pre to post. Unfortu-
nately this analysis did require complete data with the
change being the outcome variable used in the analysis.
However, there was a minimum amount of missing data
and only one outcome variable, “attitudes toward third
party access to genetic profiles,” required this type of
analysis.
Results
Physicians were primarily male, white, non-Hispanic,
and middle aged (Table 1). There were no significant dif-
ferences between the Intervention and Control Groups
with regard to demographics, years of practice, or ex-
perience with inherited breast cancer. We additionally
found no significant region × study group interaction on
the study variables, allowing for aggregation of data from
the three regions.
Knowledge
Intervention effects on the knowledge measures are re-
ported in Table 2. In both groups, knowledge about BRCA
genetics and breast/ovarian cancer risk (as measured by
the percentage of correct responses) increased signifi-
cantly (p < 0.01) after education (Intervention: 54.7 –>
74.3; Control: 53.1 –> 63.1). The increase in knowledge
was significantly greater (p < 0.01) in the web Intervention
Group (Δ = 19.6) than in the PDF Control Group
(Δ = 10.0).
In the Intervention Group, knowledge about genetic test
ordering increased significantly (p < 0.01) after education
(67.9➔80.0), but there was no increase in knowledge in the
Control Group (64.8➔64.5). The increase in knowledge
was significantly greater (p < 0.01) in the Intervention
Table 3 Changes in primary care providers’ self-efficacy and attitudes before and after intervention and control curricular
participation, in four domains
Variable Pretest Post-test Change P value
N Mean
(95% CI)
N Mean
(95% CI)
Mean
(95% CI)
Within Between
Knowledge about BRCA genetics and breast/ovarian cancer risk (11 items) % correct
Control 67 53.1 (49.5, 56.6) 61 63.1 (59.4, 66.8) 10.0 (5.8, 14.2) <0.01 <0.01
Research 66 54.7 (51.1, 58.3) 61 74.3 (70.5, 78.0) 19.6 (15.4, 23.8) <0.01
Knowledge about genetic testing (5 items) % correct
Control 67 64.8 (61.2, 68.3) 61 64.5 (60.8, 68.2) -0.3 (-3.9, 3.4) 0.89 <0.01
Research 66 67.9 (64.3, 71.4) 61 80.0 (76.3, 83.7) 12.1 (8.4, 15.8) <0.01
Knowledge about breast cancer overall % correct
Control 67 56.7 (54.0, 59.5) 61 63.5 (60.7, 66.4) 6.8 (3.8, 9.8) <0.01 <0.01
Research 66 58.8 (56.0, 61.6) 61 76.1 (73.2, 78.9) 17.2 (14.2, 20.2) <0.01
Knowledge about Shared Decision Making % correct
Control 67 63.6 (58.8, 68.4) 61 67.8 (63.7, 71.9) 4.2 (-0.9, 9.3) 0.11 0.84
Research 66 67.9 (63.1, 72.7) 61 71.4 (67.3, 75.5) 3.4 (-1.7, 8.6) 0.19
Knowledge about ethics, law, confidentiality % correct
Control 66 64.4 (59.5, 69.3) 61 70.2 (66.0, 74.4) 5.8 (0.7, 10.9) 0.03 <0.01
Research 66 65.9 (61.0, 70.8) 61 81.6 (77.4, 85.9) 15.7 (10.6, 20.8) <0.01
Knowledge about VTE % correct
Control 66 63.6 (58.6, 68.7) 61 68.3 (64.0, 72.6) 4.7 (-1.3, 10.6) 0.12 <0.01
Research 66 65.5 (60.4, 70.5) 61 86.9 (82.6, 91.2) 21.5 (15.6, 27.4) <0.01
Knowledge about ethics and perinatal/pediatric genetic testing % correct
Control 66 65.8 (60.9, 70.6) 61 76.1 (71.5, 80.7) 10.4 (4.6, 16.1) <0.01 0.08
Research 66 70.3 (65.5, 75.1) 61 87.8 (83.3, 92.4) 17.5 (11.8, 23.2) <0.01
Total Knowledge % correct
Control 66 59.1 (56.9, 61.4) 61 65.5 (63.6, 67.4) 6.3 (4.4, 8.3) <0.01 <0.01
Research 66 62.1 (59.9, 64.4) 61 75.9 (74.0, 77.8) 13.8 (11.9, 15.8) <0.01
* Linear mixed effects model
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Group (Δ = 12.1) than in the Control Group (Δ = −0.3).
There was no increase in knowledge about shared decision
making in either group. In both groups, knowledge about
ethics, the law, and confidentiality related to genetic testing
increased significantly after education (intervention:
65.9➔81.6, p < 0.01; control: 64.4➔70.2, p = 0.03). How-
ever, the increase in knowledge was significantly greater
(p < 0.01) in the Intervention Group (Δ = 15.7) than in the
Control Group (Δ = 5.8).
In the Intervention Group, knowledge related to gen-
eral genetics and venous thromboembolism increased sig-
nificantly after education (65.5➔86.9, p < 0.01), but
there was no increase in knowledge in the Control
Group (63.6➔68.3, p = 0.12). The increase in knowledge
was significantly greater (p < 0.01) in the Intervention
Group (Δ = 21.5) than in the Control Group (Δ = 4.7).
In both groups, knowledge related to ethics and peri-
natal/pediatric genetic testing increased significantly
(p < 0.01) after education (Intervention: 70.3➔87.8; Con-
trol: 65.8➔76.1). The increase in knowledge was not dif-
ferent between groups (p = 0.08).
A cumulative knowledge score based on percent correct
of the 38 above items was calculated. In both groups,
knowledge increased significantly (p < 0.01) after educa-
tion (Intervention: 62.1➔75.9; Control: 59.1➔65.5). How-
ever, the increase in knowledge was significantly greater
(p < 0.01) in the Intervention Group (Δ = 13.8) than in
the Control Group (Δ = 6.3).
Self-efficacy
After participation, PCPs’ self-efficacy improved in both
groups for both domains (P < 0.01), with modest but sig-
nificantly higher improvement in the Intervention Group
(Table 3). PCPs were initially “somewhat” confident with
their ELSI-genetics skills, improving to “more” confident
after curricular participation. PCPs were initially less
confident about their ELSI-genetics knowledge, improving
to “somewhat” to “more” confident after curricular
participation.
Attitudes
PCPs in both groups were initially neutral with regard to
the value of genetic profiling by individuals. After participa-
tion, PCPs in the Intervention Group tended to disagree
that individuals should be genetically profiled, and PCPs in
the Control Group remained neutral. PCPs in both groups
initially indicated that insurers and employers should not
have access to an individual’s genetic profile, and neither
group changed this opinion after the curriculum (Table 3).
OSVE
The OSVE assessment showed that overall the interven-
tion and Control Group both improved significantly
from pre to post OSVE; neither group improved more
than the other (Table 4).
Practice behaviors (transcript analysis of SP visits)
Based on review of SP transcripts, we found that the aver-
age physician in this study asked just 20% of the family and
personal history questions that would be appropriate in this
setting, a finding consistent with other studies [42, 43]. Phy-
sicians also fell short in their counseling about the
implications of positive test results, focusing heavily on sur-
gical options and neglecting to explore familial implica-
tions, emotional impacts, or social support, though each of
these is an essential component of the genetic counseling
process [44–47]. Furthermore, though considerable atten-
tion was devoted to ELSI issues in the web-based and
Table 4 Group comparisons for OSVE measured at PRE and POST
Variable Pretest Post-test Change Within
P-
value
Between
P-valueN Mean (95% CI) N Mean (95% CI) Mean (95% CI)
OSVE 1 Total Score (0-12)
Control 60 3.4 (3.0, 4.0) 59 4.0 (3.6, 4.6) 0.6 (0.0, 1.2) 0.05 0.56
Intervention 58 3.2 (2.6, 3.6) 59 4.0 (3.6, 4.6) 0.8 (0.2, 1.6) <0.01
OSVE 2 Total Score (0-13)
Control 61 3.8 (3.4, 4.4) 61 5.2 (4.6, 5.6) 1.2 (0.6, 1.8) <0.01 0.99
Intervention 58 4.2 (3.6, 4.6) 59 5.4 (4.8, 6.0) 1.2 (0.6, 2.0) <0.01
OSVE 3 Total Score (0-16)
Control 60 4.0 (3.4, 4.6) 61 4.6 (4.0, 5.2) 0.6 (-0.2, 1.2) 0.17 0.88
Intervention 59 4.4 (3.8, 4.8) 59 4.8 (4.2, 5.4) 0.4 (-0.4, 1.2) 0.25
OSVE Total Score (0-40)
Control 59 11.2 (10.0, 12.4) 59 13.8 (12.6, 15.0) 2.6 (1.2, 3.8) <0.01 0.69
Intervention 55 11.4 (10.0, 12.6) 57 14.2 (13.0, 15.4) 3.0 (1.6, 4.4) <0.01
*Linear mixed effects model
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control curriculum, only half of the participants ever talked
with the SP about medical record confidentiality, insurance
discrimination, and federal legal protections or the impact
of testing on relatives. Even fewer examined employment
discrimination concerns, and none explored the important
issue of social stigma [45]. However, intervention doctors
were more likely to engage in key shared decision-making
behaviors, such as suggesting the choice of testing was up to
the patient (control doctors were more likely to recommend
the test), encouraging a discussion with a genetic counsellor,
and asking about prostate and ovarian cancer [22].
SPs also provided a post-encounter evaluation via a 10
item, five-point Likert scale questionnaire focused on
clinician communication and shared decision making
skills. While this type of evaluation was more subjective
than the transcript analysis, SPs were blind as to which
group each physician was in. Though not statistically
significant, there was an overall trend by intervention
physicians toward higher ratings (strongly agree plus
agree) including communication skills (97% vs 91%),
“offering me different options for care” (95% vs 90%),
“encouraged me to ask questions” (77 vs 73), “I felt
the doctor listened to me” (92% vs 80%), “I felt the
doctor took enough time with me” (91% vs 88%).
There were no areas where the Control Group per-
formed better.
Attitude toward tools
Satisfaction with tools
The Control Group reported completing on average 87%
of the curriculum; the intervention reported completing
92%. Compared to the Control Group, intervention PCPs
were significantly more likely to rate the curriculum highly
(p < .0001). They were also significantly more likely to rec-
ommend the curriculum to colleagues (p < .0001). When
asked about the impact of what they learned, the
Intervention Group rated several areas significantly higher
than for the Control Group: the acquisition of ELSI (eth-
ical legal, and social) knowledge (p < 0.0002), confidence
in caring for people with genetic conditions (p < .02),
communication issues around genetics (p < 0.01) and abil-
ity to care for people with genetic disorders (p < 0.01).
Intervention PCPs (78%) reported that they would prefer
to participate in this web-based program compared with
the option of reading materials (either online or in paper)
or attending a CME class (results not presented in tabular
form).
Advantages/disadvantages of the tool
Intervention Group PCPs in their end-of-curriculum survey
responses rated learning related to medical management,
genetic core concepts, and ELSI issues significantly higher
than the Control Group. In comparison with traditional
curricula, Intervention Group PCPs felt that their curricu-
lum offered several advantages including being engaging,
addressing communication styles, and providing informa-
tion of clinical relevance (Table 5). There was no difference
between groups in their estimated likelihood that clinical
changes would result from the CME learning activity. Par-
ticipants were also asked about perceived barriers to imple-
menting learned materials (cost, lack of time for patient
care, lack of administrative support, insurance coverage/ re-
imbursement issues, patient compliance issues, uncertainty
about professional consensus) to implementing learned ma-
terials. While both groups perceived significant barriers,
there were no differences between groups.
Discussion
With the rapid proliferation of genetic tests, the need for
genetic counseling services will continue to grow. Along-
side trained genetic counselors, informed primary care
physicians who are able to engage in shared decision-
making and evidence-based test ordering will be crucial
Table 5 Comparison of CME medical education curriculum with interactive web-based education
“In comparison with traditional CME medical education
curricula, how well does this type of interactive web-based
education meet the following goals?”
Worse, n (%) About the same, n (%) Better, n (%)tter, n (%) P
CNTL INV CNTL INV CNTL INV
Fits into your schedule 4(6.56) 4(6.56) 12(19.67) 13(21.31) 45(73.77) 44(72.13) NS
Demonstrates good/bad communication styles 14(22.95) 0(0.00) 35(57.38) 17(27.87) 12(19.67) 44(72.13) 0.0001
Stimulates self-directed learning 7(11.48) 2(3.28) 28(45.90) 22(36.07) 26(42.62) 37(60.66) 0.0271
Provide learning flexibility in time/place 0(0.00) 1(1.64) 11(18.03) 9(14.75) 50(81.97) 51(83.61) NS
Provides opportunities to explore additional clinical content 9(14.75) 1(1.64) 40(65.57) 31(50.82) 12(19.67) 29(47.54) 0.0002
Answers practical questions about the content 20(32.79) 9(14.75) 30(49.18) 32(52.46) 11(18.03) 20(32.79) 0.0102
Engages you in the content 13(21.31) 2(3.28) 28(45.90) 13(21.31) 20(32.79) 46(75.41) 0.0001
Help you utilize content in the care of patients 8(13.11) 1(1.64) 37(60.66) 28(45.90) 16(26.23) 32(52.46) 0.0008
Facilitates long-term retention of knowledge 12(19.67 2(3.28) 40(65.57) 39(63.93) 9(14.75) 20(32.79) 0.0013
Stimulates self-reflection about your skills 11(18.03) 1(1.64) 28(45.90) 26(42.62) 22(36.07) 34(55.74) 0.0050
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in responding to this growth. However, many primary
care physicians have an insufficient understanding of the
basics of clinical genetics, evidence-based screening,
communication approaches that encourage shared
decision-making, and awareness of ethical and social is-
sues related to screening for genetic mutations [4]. Thus,
there is a need for effective targeted interventions that
improve physician competencies with regard to genetic
testing, counseling, and communication. In this study,
we found that compared to standard curricular mate-
rials, an interactive web-based CME curriculum was
more effective at increasing physician knowledge around
genetic testing, and improving shared decision making
behaviors, though it had a small effect on attitudes and
minimally impacted clinical behaviors around ethical,
legal, and social discussions around genetic testing.
Overall, PCPs in the Intervention Group showed greater
increases in knowledge compared to the Control Group.
Intervention PCPs were also more satisfied with the edu-
cational materials, and more confident in their ELSI gen-
etics knowledge and skills compared to those receiving
traditional CME materials. Intervention clinicians were
also significantly better at implementing shared decision
making. While both groups received information around
shared decision making in curricular materials, and while
there was no difference between the groups with regard to
knowledge of shared decision making, intervention doc-
tors were more likely to engage in shared decision-making
in standardized patient visits as determined by transcript
analysis and SPs rated them higher on a 10 item question-
naire around communication and shared decision making
skills. This discrepancy between knowledge and applica-
tion has important implications for shared decision mak-
ing and for our curriculum. The interactive tool required
interaction and engagement with clinical questions, obser-
vation of communication skills, and discussions of barriers
to effective genetic testing. This may imply that while the
fund of knowledge around SDM may be common and
well-accepted among PCPs, implementation may require
a demonstrative curriculum such as ours which allowed
PCPs to see various models of implementation in multiple
clinical situations.
In general, based on SP ratings and review of SP-
physician transcripts, the intervention’s impact on practice
behaviors was only minimally better than the Control
Group. Physicians in both groups infrequently performed
key counseling behaviors related to inherited breast cancer
(family history of cancer, questions about onset of breast
cancer in close relatives, or discussion of risks and benefit
of screening either by genetic testing or imaging), regard-
less of whether they had completed the web-based train-
ing or read traditional clinical reviews. Though the study
was not designed to determine why such behaviors were
or were not performed, the results raise the question of
what additional opportunities for reinforcement, applica-
tion, or prompting would be needed to facilitate behavior
change. Our findings suggest that increasing knowledge
and confidence do not necessarily translate to actions in
the clinical setting, and further research is warranted to
help identify strategies that impact clinical interactions
around genetic diseases. This finding is not unique, as
additional studies looking to impact behavior have often
proved ineffective or not sustainable over time [21].
There were several limitations that deserve mention-
ing. A number of physicians invited to participate did
not respond to the invitation, leading to the possibility
of a selection bias wherein motivated and interested
physicians were overrepresented. The effect of such a se-
lection bias would be to overstate the true level of pro-
vider ability in the domain studied. Second, the SPs were
announced, and although physicians had no advanced
knowledge of the clinical presentation, they did know
that they were being evaluated. They may, therefore,
have exhibited a higher level of clinical skills than would
have been observed had the SPs been unannounced [39].
Third, we examined just one genetic condition; findings
may not generalize to other conditions. Finally, the study
was carried out in only two states.
Conclusion
This trial evaluated a novel web-based educational inter-
vention aimed at improving communication skills, address-
ing ELSI issues, and enhancing shared decision-making. To
practice high quality medicine, it is necessary to have an
ongoing commitment to acquiring new information but as
it turns out, this is not sufficient. Traditional methods of
continuing medical education have relied heavily upon large
group dissemination of information such as lectures and/or
readings. While our intervention was deemed more enjoy-
able, demonstrated significant factual learning and reten-
tion, and improved implementation of shared decision
making, there were few differences in ELSI behaviors be-
tween the intervention and control groups. There is a
growing literature that suggests that behavior change re-
quires not only readiness to change by the physician (pro-
viding the knowledge and background and demonstrating
“best practice”) but also behavioral prompts to increase up-
take such as clinical decision support, just-in-time informa-
tion availability, clinician reimbursement for genetics-
related activities, and prompting by an educated consumer
[5, 21, 48, 49]. Perhaps the missing element, therefore, is
that busy physicians need system-level support to engage in
meaningful discussions around the ethical, legal, and social
implications of genetic testing. In this study as well as
others, knowledge and attitudes around genetic issues have
been shown to increase with interactive educational inter-
ventions. However, we have confirmed, like others, that
brief educational interventions are unlikely to impact
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clinician behaviors around genetic interactions long-term
[48]. Thus, we concur with other studies that suggest that
measuring changes in knowledge and attitudes should not
be the prime objective of educational interventions around
genetics moving forward [21]. Instead, measuring ethical,
legal, and social awareness of genetic issues, as well as the
ability to locate and utilize that genetic information when
needed- may be a better aim for future interventions. Thus,
the next step in promoting active engagement between
doctors and patients may be to put into place the tools and
infrastructure that allow clinicians to easily access
evidence-based information during the encounter, prepar-
ing physicians to engage in the joint discussions around
genetic issues that patients need.
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